ReviewFrontiers in pharmacology2020

CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas.

Matteo Cassandri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.